You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CAR19

Showing 26 - 50 of 1,084
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission, Acute Lymphoblastic Leukemia

Recruiting
  • Acute Lymphoblastic Leukemia, in Relapse
  • +5 more
  • CAR-20/19-T cells (1 x 10^5 CAR-20/19-T cells/kg)
  • +4 more
  • Milwaukee, Wisconsin
    Medical College of Wisconsin
Sep 22, 2022

B-cell Acute Lymphoblastic Leukemia, B Lineage Lymphoblastic Lymphoma Trial in Philadelphia (Autologous, humanized anti-CD22 CAR

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • B Lineage Lymphoblastic Lymphoma
  • Autologous, humanized anti-CD22 CAR T cell therapy (CART22-65s)
  • Autologous, humanized anti-CD19 CAR T cell therapy (huCART19)
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Jan 25, 2023

Non Hodgkin's Lymphoma Trial in Beijing (TRAC and Power3 Genes Knock-out Allogeneic CD19-targeting CAR-T cell (ATHENA CAR-T),

Not yet recruiting
  • Non Hodgkin's Lymphoma
  • TRAC and Power3 Genes Knock-out Allogeneic CD19-targeting CAR-T cell (ATHENA CAR-T)
  • +2 more
  • Beijing, China
  • +2 more
Aug 23, 2023

Refractory or Relapsed B-cell Non-Hodgkin Lymphoma Trial in Shanghai (dualCAR-NK19/70 cell)

Recruiting
  • Refractory or Relapsed B-cell Non-Hodgkin Lymphoma
  • dualCAR-NK19/70 cell
  • Shanghai, Shanghai, China
    Shanghai Tongji Hospital, Tongji University School of Medicine
Apr 24, 2023

B-Cell Non Hodgkin Lymphoma, B-Cell Acute Lymphoblastic Leukemia Trial in Hanoi (anti-CD19 CAR T-cells)

Recruiting
  • B-Cell Non Hodgkin Lymphoma
  • B-Cell Acute Lymphoblastic Leukemia
  • anti-CD19 CAR T-cells
  • Hanoi, Vietnam
    Vinmec Research Institute of Stem Cell and Gene Technology
Sep 5, 2023

Acute Myeloid Leukemia Trial in Ramat Gan (CAR-T CD19)

Recruiting
  • Acute Myeloid Leukemia
  • CAR-T CD19
  • Ramat Gan, Israel
    Chaim Sheba Medical Center
Oct 30, 2022

COVID-19 ANtibody Responses in Cystic Fibrosis: CAR-CF

Recruiting
  • COVID-19
  • Cystic Fibrosis
    • Barcelona, Spain
      Hospital Universitari Vall d'Hebron. Cystic Fibrosis Unit
    Feb 23, 2023

    SLE (Systemic Lupus) Trial in Bangkok (CAR T-cell therapy)

    Not yet recruiting
    • SLE (Systemic Lupus)
    • CAR T-cell therapy
    • Bangkok, Please Select, Thailand
      King Chulalongkorn Memorial Hospital
    Nov 23, 2023

    B-Cell Leukemia, B-Cell Lymphoma, B-cell Tumors Trial in Kunming (Anti-CD19 Autologous CAR-T Cell Infusion)

    Recruiting
    • B-Cell Leukemia
    • +2 more
    • Anti-CD19 Autologous CAR-T Cell Infusion
    • Kunming, Yunnan, China
      920th Hospital of Joint Logistics Support Force of People's Libe
    Jul 9, 2023

    Diffuse Large B-cell Lymphoma Trial in Hangzhou, Ningbo (CD19-7×19 CAR-T combined with Tislelizumab)

    Recruiting
    • Diffuse Large B-cell Lymphoma
    • CD19-7×19 CAR-T combined with Tislelizumab
    • Hangzhou, Zhejiang, China
    • +1 more
    Dec 12, 2022

    Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia, Refractory Trial in Memphis (drug, device, biological)

    Active, not recruiting
    • Acute Lymphoblastic Leukemia, in Relapse
    • Acute Lymphoblastic Leukemia, Refractory
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Jan 3, 2023

    Lymphoma Trial in Seattle (biological, other, procedure)

    Not yet recruiting
    • Lymphoma
    • Immune Globulin Infusion (Human), 10% Solution
    • +5 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jul 21, 2023

    Diffuse Large B Cell Lymphoma Trial (anti-CD19 CAR NK cells)

    Not yet recruiting
    • Diffuse Large B Cell Lymphoma
    • anti-CD19 CAR NK cells
    • (no location specified)
    Dec 21, 2022

    B-cell Acute Lymphoblastic Leukemia Trial in Nanchang (Human CD19 Targeted DASH CAR-T Cells Injection)

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • Human CD19 Targeted DASH CAR-T Cells Injection
    • Nanchang, Jiangxi, China
      The Second Affiliated Hospital of Nanchang University
    Dec 13, 2022

    B-cell Lymphoma Trial in Xuzhou (ASCT+CAR-T Cell Infusion)

    Recruiting
    • B-cell Lymphoma
    • ASCT+CAR-T Cell Infusion
    • Xuzhou, Jiangsu, China
      The Affiliated Hospital of Xuzhou Medical University
    Feb 23, 2023

    B-cell Non Hodgkin Lymphoma Trial in Xuzhou (regimen with BTK inhibitor +Anti-CD19 CAR T cells)

    Recruiting
    • B-cell Non Hodgkin Lymphoma
    • regimen with BTK inhibitor +Anti-CD19 CAR T cells
    • Xuzhou, Jiangsu, China
      The Affiliated Hospital of Xuzhou Medical University
    Feb 23, 2023

    Non Hodgkin Lymphoma Trial (TMhuCART19-IL18)

    Not yet recruiting
    • Non Hodgkin Lymphoma
    • TMhuCART19-IL18
    • (no location specified)
    Aug 2, 2023

    Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited Trial in Zhengzhou (ThisCART19A, Fludarabine Pill, Cyclophosphamide)

    Not yet recruiting
    • Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited
    • Zhengzhou, Henan, China
      Henan cancer hospital
    Nov 28, 2022

    Relapsed or Refractory B-cell Non-Hodgkin Lymphoma Trial in Suzhou (Obinutuzumab, Zanubrutinib, Lenalidomide)

    Enrolling by invitation
    • Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
    • Suzhou, Jiangsu, China
      the First Affiliated Hospital of Soochow University
    Mar 22, 2023

    Systemic Lupus Erythematosus (SLE) Trial (BRL-301)

    Not yet recruiting
    • Systemic Lupus Erythematosus (SLE)
    • BRL-301
    • (no location specified)
    Aug 13, 2023

    B-Lymphoid Malignancies, Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia Trial in Houston (Fludarabine,

    Active, not recruiting
    • B-Lymphoid Malignancies
    • +3 more
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Aug 1, 2022

    Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Chronic Lymphocytic Leukemia Trial in Milwaukee (CAR-20/19-T cells (1.0 x10^5

    Completed
    Has Results
    • Lymphoma, Non-Hodgkin
    • +3 more
    • CAR-20/19-T cells (1.0 x10^5 CAR-20/19-T cells/kg)
    • +3 more
    • Milwaukee, Wisconsin
      Froedtert Hospital & Medical College of Wisconsin
    Jun 26, 2022

    Non-hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in Boston (CD79b-19 CAR T cells,

    Not yet recruiting
    • Non-hodgkin Lymphoma
    • +9 more
    • CD79b-19 CAR T cells
    • +2 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    Sep 6, 2023

    Acute Lymphoblastic Leukemia, B-cell Lymphoma, Chronic Lymphocytic Leukemia Trial in Xuzhou (allogenic CD19-CAR-NK cells)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +2 more
    • allogenic CD19-CAR-NK cells
    • Xuzhou, Jiangsu, China
      The Affiliated Hospital of Xuzhou Medical University
    Feb 11, 2023

    Lymphoblastic Leukemia, Lymphoblastic Leukemia in Children, Lymphoblastic Leukemia, Acute Adult Trial in Singapore (Anti-CD19

    Recruiting
    • Lymphoblastic Leukemia
    • +5 more
    • Anti-CD19 CAR T-cells
    • Singapore, Singapore
    • +1 more
    Dec 4, 2022